Psychedelics – assisted psychotherapy in Maryland
Maryland is right next to Washington, D.C., which is debating whether or not to decriminalize psilocybin. This might or may not have an effect on Maryland’s public and legal perceptions of magic mushrooms. For the time being, people cannot possess, sell, or transport any psilocybin-containing mushrooms.
It’s really ironic that Maryland – home to the world’s leading psychedelic research center, the Johns Hopkins Center for Psychedelic & Consciousness Research, which opened in 2019, still classifies psilocybin as a Schedule I substance that can’t be used therapeutically.
The efficacy of psilocybin as a new medication for opioid addiction, Alzheimer’s disease, PTSD, post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol usage in people with major depression will be determined in upcoming research. The researchers hope to develop precision medicine therapies that are personalized to and patient’s unique needs.